Home » Newsletters » BioWorld Science

BioWorld Science

May 30, 2014

View Archived Issues

Muscle homing peptide-PMO conjugate shows promise in dystrophin-deficient mice

Novel bispecific anti-VEGF/ANG-2 MAb for the treatment of ocular disorders

Vitamin D supplementation tested for prediabetes progression treatment

Extended-spectrum pleuromutilins tested for efficacy against antimicrobial-resistant infections

Clinical evaluation of a dendritic cell-targeting vaccine for the treatment of refractory tumors

Investigators develop and characterize protein kinase C interaction disruptors

Nonhuman primate efficacy and human safety assessed for agent against Marburg virus

Bristol-Myers Squibb patents novel NS3/NS4A inhibitors for HCV

Novel multipeptide cocktail compositions reported by Dana-Farber Cancer Institute

Bayer Schering Pharma patents novel sGC activators

Researchers at Medeia Therapeutics synthesize novel agents for neurodegenerative disorders

Single-chain insulin analogues disclosed by Case Western Reserve University

Small-molecule Abeta oligomer receptor antagonist reported for Alzheimer's disease

Xencor begins phase Ia study of XmAb-7195 for asthma

Lilly presents novel MOGAT2 inhibitors for hypertriglyceridemia

PolyTherics and Alpha Cancer Technologies establish collaboration

Trimel reports topline phase II results for Tefina

UCB Celltech initiates phase I trial in patients with psoriatic arthritis

FDA accepts for filing Rockwell's NDA for iron replacement therapy

Reata and AbbVie to initiate phase II trial of lotion to prevent radiation dermatitis

Transgene discloses phase IIb data for TG-4010

Tekmira to initiate phase I/II trial of RNAi agent in hepatocellular carcinoma

Dosing under way in phase IIa study of LPCN-1111 in hypogonadal men

OncoCyte and Cornell University collaborate to develop lung cancer diagnostic

Partners in Parkinson's initiative launched by the Michael J. Fox Foundation and AbbVie

Micromedic to develop diagnostic for risk of bisphosphonate-related osteonecrosis of the jaw

Sorafenib gains E.U. approval for thyroid cancer

NDA submission for safinamide for Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...